SMis Generics, Super -Generics and Patent Strategies

Venue: Millennium Gloucester Hotel

Location: London, United Kingdom

Event Date/Time: May 11, 2011 End Date/Time: May 12, 2011
Early Registration Date: Feb 28, 2011
Report as Spam


The SMi Group is proud to announce the latest in its series of successful Generics, Super-Generics, and Patent Strategies conferences, taking place in London on the 11th and 12th May, 2011.

Offering a comprehensive two day program, this conference is designed to keep you up to date with the latest legislative, regulatory, and global developments in the generic marketplace, whilst providing networking opportunities with the key industry thought leaders and decision makers. This year promises to help pave the way to your future business success in the modern generics industry.

Recent trends in EU competition policy
Structural changes in the global pharmaceutical marketplace
The development of super-generics
Investment opportunities and challenges in the Generics industry for the UK
The risk of entering China with branded generics in 2011

All designed to provide the most complete and content driven Generics conference around.

Pascal Brenneisen, Country Head, Sandoz UK
Brian Tempest, Chairman, Hale & Tempest (Ex CEO, Ranbaxy)
Deepak Murpani, Vice President, Product Development, Genepharm Group
Jozef Belcik, Commercial Director, Branded Generics, Global Marketing and Sales Operations, AstraZeneca
Richard Dicicco, Chairman, Harvest Moon Pharmaceuticals
Ineke Braat, CEO, PanGenerika
Manoj Paruthi, Senior Manager, Head Branded Generics, Hikma Pharmaceuticals
Ivanka Atanasova, Chief Expert, Bulgarian Drug Agency (BDA)
Ayhan Aslan, Director, International Commercial Division, MN Pharmaceuticals
Duncan Curley, Director, Innovate Legal
Margaret Hsiao, President, Harvest Moon Pharmaceuticals
Martin Votava, CHMP member (2007-10), Head of Pharmacology Department, Charles University
Bernd Stoiber, Consultant, Lead Training (Ex Head of Mass Markets, Novartis)
Aman Trehan, Deputy General Manager-Intellectual Property, Cadila Health Care
Paul Csiszár, Director, European Commission, Competition Directorate General
Bruce Murdoch, Commercial Director, Stravencon
Lorna Brazell, Partner, Bird & Bird


Additional Information

Plus two Interactive Workshops: Valsartan: Negotiating the EU patent thicket for a blockbuster anti-hypertensive Hosted by Duncan Curley, Director, Innovate Legal 8.30-12.30pm - Tuesday 10th May, 2011 Generics in the emerging markets: Boom or bubble? Hosted by Paul Mendelsohn. CEO at Pharmawise And co-hosted by Frances Cloud, Founder, Pharmacloud 1.30-5.30pm - Tuesday 10th May, 2011